Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
Matuzumab is a humanized IgG1 monoclonal antibody against human EGFR. As it only has approximately 10% murine origin it has limited immunogenicity, and being IgG1 it is capable of inducing antibody dependent cell cytotoxicity (ADCC).Matuzumab is produced in mammalian (Chinese hamster ovary) cell culture.
Matuzumab is supplied at a concentration of 10 mg/mL as a sterile, preservative-free, non-pyrogenic, clear, colorless liquid, which contains 20mM Tris buffered saline and Water for Injection.
Properties
Name | Matuzumab |
CAS NO. | 339186-68-4 |
Type | Whole antibody |
Source | Humanized |
Target | EGFR |
Clone | Monoclone |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China(Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Matuzumab
